Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
The meeting is designed to provide clinicians and allied health professionals with an update on current issues in the management of diseases affecting haematology patients. The programme combines lectures, workshop sessions and discussion across a range of haematological malignancies.
Programme highlights
The programme opens with a myeloma workshop chaired by Dr Victoria Campbell, with sessions on controversies in myeloma front-line treatment and relapsed/refractory multiple myeloma. Speakers listed in the programme include Professor Gordon Cook and Dr Charlotte Pawlyn.
The wider agenda includes sessions on CLL, CAR-T, mantle cell lymphoma and follicular lymphoma, DLBCL decision-making, AML, adult ALL and MPN/MF. Topics include whether all AML patients should now receive venetoclax, the role of allogeneic transplant in very high-risk AML patients and the latest thinking in treatment options for MPN.
Who it is for
This event may be of interest to doctors, nurses, pharmacists, allied health professionals and researchers involved in haematology, myeloma care, lymphoma, leukaemia, cellular therapies or multidisciplinary cancer services.
Registration is free of charge for healthcare professionals working within the NHS.
–
